Federal Register / Vol. 65, No. 75 / Tuesday, April 18, 2000 / Notices 20823

Number of respondents: 988.

Small businesses are affected.

General description of report: Title I

of the Consumer Credit Protection Act

(15 U.S.C. 1601 et seq.) authorizes the

Board to issue regulations to carry out

the provisions of the Consumer Credit

Protection Act (15 U.S.C. 1604(a)). Since

the Federal Reserve does not collect any

information, no issue of confidentiality

arises. Transaction-or account-specific

disclosures and billing error allegations

are not publicly available and are

confidential between the creditor and

consumer. Abstract: Regulation Z (12

CFR part 226) implements the Truth in

Lending Act (15 U.S.C. 1601 et seq.).

The act and regulation ensure adequate

disclosure of the costs and terms of

credit to consumers on an eventgenerated basis. For open-end credit

(revolving credit accounts), creditors are

required to disclose information about

the initial costs and terms and to

provide periodic statements of account

activity, notices of change in terms, and

statements of rights concerning billing

error procedures. The regulation also

requires specific types of disclosures for

credit and charge card accounts, and

home equity plans. For closed-end loans

(such as mortgage and installment

loans) cost disclosures are required to be

provided prior to consummation.

Specific products trigger special

disclosures, such as reverse mortgages,

certain variable rate loans, and certain

mortgages with rates and fees above a

specific amount. Regulation Z also

contains rules concerning credit

advertising. Creditors are required to

retain records as evidence of

compliance with Regulation Z for

twenty-four months (subpart D, section

226.25).

Board of Governors of the Federal Reserve

System, April 13, 2000.

Jennifer J. Johnson,

Secretary of the Board.

[FR Doc. 00–9677 Filed 4–17–00; 8:45 am]

BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM

Change in Bank Control Notices;

Acquisitions of Shares of Banks or

Bank Holding Companies

The notificants listed below have

applied under the Change in Bank

Control Act (12 U.S.C. 1817(j)) and

§ 225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire a bank or bank

holding company. The factors that are

considered in acting on the notices are

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. The notices

also will be available for inspection at

the offices of the Board of Governors.

Interested persons may express their

views in writing to the Reserve Bank

indicated for that notice or to the offices

of the Board of Governors. Comments

must be received not later than May 3,

2000.

A. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri

63166–2034:

1. Sara J. Harrison, Little Rock,

Arkansas; to retain voting shares of

Southern State Bancshares, Inc.,

Malvern, Arkansas, and thereby

indirectly retain voting shares of

Southern State Bank, Malvern,

Arkansas.

Board of Governors of the Federal Reserve

System, April 13, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–9678 Filed 4–17–00; 8:45 am]

BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank Holding Company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR Part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The applications listed below, as well

as other related filings required by the

Board, are available for immediate

inspection at the Federal Reserve Bank

indicated. The application also will be

available for inspection at the offices of

the Board of Governors. Interested

persons may express their views in

writing on the standards enumerated in

the BHC Act (12 U.S.C. 1842(c)). If the

proposal also involves the acquisition of

a nonbanking company, the review also

includes whether the acquisition of the

nonbanking company complies with the

standards in section 4 of the BHC Act

(12 U.S.C. 1843). Unless otherwise

noted, nonbanking activities will be

conducted throughout the United States.

Additional information on all bank

holding companies may be obtained

from the National Information Center

website at www.ffiec.gov/nic/.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than May 12, 2000.

A. Federal Reserve Bank of

Richmond (A. Linwood Gill, III, Vice

President) 701 East Byrd Street,

Richmond, Virginia 23261–4528:

1. Wachovia Corporation, WinstonSalem, North Carolina; to merge with

Commerce National Corporation, Winter

Park, Florida, and thereby indirectly

acquire National Bank of Commerce,

Winter Park, Florida.

Board of Governors of the Federal

Reserve System, April 13, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–9679 Filed 4–17–00; 8:45 am]

BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM

Notice of Proposals To Engage in

Permissible Nonbanking Activities or

To Acquire Companies That Are

Engaged in Permissible Nonbanking

Activities

The companies listed in this notice

have given notice under section 4 of the

Bank Holding Company Act (12 U.S.C.

1843) (BHC Act) and Regulation Y, (12

CFR part 225) to engage de novo, or to

acquire or control voting securities or

assets of a company, including the

companies listed below, that engages

either directly or through a subsidiary or

other company, in a nonbanking activity

that is listed in § 225.28 of Regulation Y

(12 CFR 225.28) or that the Board has

determined by Order to be closely

related to banking and permissible for

bank holding companies. Unless

otherwise noted, these activities will be

conducted throughout the United States.

Each notice is available for inspection

at the Federal Reserve Bank indicated.

The notice also will be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether the proposal complies

with the standards of section 4 of the

BHC Act. Additional information on all

bank holding companies may be

obtained from the National Information

Center website at www.ffiec.gov/nic/.

Unless otherwise noted, comments

regarding the applications must be

received at the Reserve Bank indicated

or the offices of the Board of Governors

not later than May 2, 2000.

A. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

20824 Federal Register / Vol. 65, No. 75 / Tuesday, April 18, 2000 / Notices

Locust Street, St. Louis, Missouri

63166–2034:

1. National Commerce

Bancorporation, Memphis, Tennessee;

through its existing wholly owned

nonbank subsidiary, TransPlatinum

Service Corp., Nashville, Tennessee, to

acquire Prime Financial Services, Inc.,

Dresden, Tennessee, and thereby engage

in factoring activities, pursuant to

§ 225.28(b)(1) of Regulation Y.

Board of Governors of the Federal Reserve

System, April 12, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–9601 Filed 4–17–00; 8:45 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration on Aging

[Program Announcement No. AoA–00–3]

Fiscal Year 2000 Program

Announcement; Availability of Funds

and Notice Regarding Applications

AGENCY: Administration on Aging, HHS.

ACTION: Announcement of availability of

funds and request for applications to

establish, or expand and improve,

Statewide Senior Legal Hotlines whose

purpose is to advance the quality and

accessibility of the legal assistance

provided to older people.

SUMMARY: The Administration on Aging

announces that under this program

announcement it will hold a

competition for grant awards for four (4)

to five (5) projects that establish, or

expand and improve, Statewide Senior

Legal Hotlines aimed at advancing the

quality and accessibility of the legal

assistance provided to older people.

The deadline date for the submission

of applications is June 16, 2000.

Eligibility for grant awards is limited to

public and/or nonprofit agencies,

organizations, and institutions

experienced in providing legal

assistance to older persons.

Application kits are available by

writing to the Department of Health and

Human Services, Administration on

Aging, Office of Program Development,

330 Independence Avenue, SW, Room

4264, Washington, DC 20201, or by

calling 202/619–2987.

Dated: April 12, 2000.

Jeanette C. Takamura,

Assistant Secretary for Aging.

[FR Doc. 00–9643 Filed 4–17–00; 8:45 am]

BILLING CODE 4154–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Disease, Disability and Injury

Prevention and Control Special

Emphasis Panel: Human

Immunodeficiency Virus Prevention

Projects for Community-Based

Organizations, Program

Announcement #00023

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting.

Name: Disease, Disability and Injury

Prevention and Control Special Emphasis

Panel: Human Immunodeficiency Virus

Prevention Projects for Community-Based

Organizations, Program Announcement

#00023.

Times and Dates: 9 a.m.–9:15 a.m., April

14, 2000 (Open); 9:15 a.m.–12 p.m., April 14,

2000 (Closed).

Place: This meeting will be conducted in

two separate, simultaneous conference call

sessions. To participate, please dial 1–800–

713–1971 and when prompted, enter

participant code #848941, and 1–800–713–

1971 and when prompted, enter participant

code #868508. The call will only be open to

the public for the first fifteen minutes, after

which the review process will begin.

Status: Portions of the meeting will be

closed to the public in accordance with

provisions set forth in section 552b(c)(4) and

(6), Title 5 U.S.C., and the Determination of

the Associate Director for Management and

Operations, CDC, pursuant to Public Law 92–

463.

Matters To Be Discussed: The meeting will

include the review, discussion, and

evaluation of five applications received in

response to Program Announcement #00023.

These five applications were originally

deemed ineligible, however, after careful

reconsideration, it was determined that they

should be given the same consideration as

applications reviewed during the original

SEP meeting that took place March 20–24,

2000.

Contact Person for More Information:

Megan Foley or Beth Wolfe, Prevention

Support Office, National Center for HIV,

STD, and TB Prevention, CDC, Corporate

Square Office Park, 11 Corporate Square

Boulevard, M/S E07, Atlanta, Georgia 30329,

telephone 404/639–8025, e-mail

MZF3@cdc.gov or EOW1@cdc.gov.

This notice is being published less than 15

days in advance of the meeting due to

administrative oversight and program delays.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register Notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: April 12, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–9608 Filed 4–13–00; 11:52 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Albendazole Suspension for Goats;

Availability of Data

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

availability of effectiveness, target

animal safety, and human food safety,

and environmental data that may be

used in support of a new animal drug

application (NADA) or supplemental

NADA for oral use of albendazole

suspension for treatment of adult liver

flukes in nonlactating goats. The data,

contained in Public Master File (PMF)

5582, were compiled under National

Research Support Project–7 (NRSP–7), a

national agricultural research program

for obtaining clearances for use of new

drugs in minor animal species and for

special uses.

ADDRESSES: Submit NADA’s or

supplemental NADA’s to the Document

Control Unit (HFV–199), Center for

Veterinary Medicine, Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855.

FOR FURTHER INFORMATION CONTACT:

Gillian A. Comyn, Center for Veterinary

Medicine (HFV–135), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–827–7568.

SUPPLEMENTARY INFORMATION:

Albendazole suspension, used for the

treatment of adult liver flukes (Fasciola

hepatica) in nonlactating goats, is a new

animal drug under section 201(v) of the

Federal Food, Drug, and Cosmetic Act

(the act) (21 U.S.C. 321(v)). As a new

animal drug, albendazole is subject to

section 512 of the act (21 U.S.C. 360b),

requiring that its uses in goats be the

subject of an approved NADA or

supplemental NADA. Goats are a minor

species under § 514.1(d)(1)(ii) (21 CFR

514.1(d)(1)(ii)).

The NRSP–7 Project, Western Region,

College of Veterinary Medicine,

University of California, Davis, CA

95616, has provided target animal

safety, effectiveness, human food safety,

and environmental data for oral use of